Measles claims territory in District East
The future of a nation relies heavily on the health and well-being of its children, who must be protected from childhood diseases through rigorous vaccination drives. Unfortunately, in Sindh, where routine immunization remains a challenge, diseases like measles continue to nip the buds of the country.
According to the Expanded Program on Immunization (EPI) of the Sindh Health Department, over 5,000 children have been brought with symptoms of measles across hospitals in Sindh, where 31 children have died between January and April 2025. Furthermore, across seven districts of Karachi, 2,242 children were brought to different hospitals with symptoms of measles, the presence of which was confirmed through a laboratory test in 948 children.
While speaking of the recent epidemic, Dr Raj Kumar, Project Director of the EPI at the Ministry of Health, confirmed that the outbreak was concentrated in District East, where out of 407 suspected cases, 247 children were confirmed to have measles. "Conversely, in the Central district, 476 children were brought with symptoms of measles, out of which 100 children were confirmed carriers. Five deaths occurred in Karachi, all of which were reported from District East," claimed Dr Kumar, while speaking of the area where no vaccination drive against measles has been conducted this year.
One such grieving parent was Amer Ali, father of 4-year-old Hasnain, who succumbed to measles. "My son was under treatment at a private hospital since the past 15 days. When his condition worsened, he was brought to the NICHD hospital, where he passed away. He had developed pneumonia along with measles, which caused him severe respiratory distress. Although we had administered both doses of the measles vaccine to our son, we still could not save his life," cried Ali.
Similarly, parents of another child brought to the emergency ward at Lyari Hospital revealed that their son had been experiencing fever and a rash on his body for several days. "When the child was brought to the emergency ward, the doctor informed that he had contracted measles. Our boy received medical treatment at the emergency ward, and luckily his condition has improved," said the parents.
According to Dr Waseem Jamalvi, President of the Pakistan Paediatric Association Sindh, even today many children in the province remain unvaccinated against measles. "If routine vaccination is ensured, the incidence of measles can be reduced. Parents are not getting their children vaccinated against measles. While some get the initial vaccinations, many miss out on the measles vaccine. The Health Department has a sufficient supply of the measles vaccine and has made it available at every EPI centre. Children who are not vaccinated against measles are more likely to contract the disease. Therefore, all parents are urged to get their children vaccinated against measles and complete the full course of protective vaccinations against 12 diseases," implored Dr Jamalvi.
Likewise, Dr Ikram Sultan, a health expert also attributed the rapid spread of measles to the low vaccination rate. "Measles is highly contagious, and despite vaccination, the number of children affected by measles is increasing. However, not vaccinating children against measles is a major reason behind the spread of this epidemic. Some affected children are those who were vaccinated, but due to weak immunity, they fell ill. Babies who are not breastfed or are suffering from nutritional deficiencies have weakened immunity and are at risk of acquiring measles. In Pakistan, children are administered measles vaccine at 9 and 15 months of age. If a child receives both doses of the vaccine, they can be effectively protected against measles," said Dr Sultan.
"The Health Department of Sindh will launch a special campaign in October, in which 8,226,945 children will be administered the measles vaccine. Under the EPI program, children are given two doses of the MMR vaccine to protect against measles, mumps, and rubella," announced Dr Kumar.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
5 hours ago
- Business Recorder
Pakistan's vaccine independence: a national imperative
Pakistan stands at a critical crossroads in public health policy. With seven million births annually and a population growth rate of 2.55%, our nation faces an unprecedented challenge in vaccine security that demands immediate and decisive action. The looming withdrawal of GAVI support by 2031 presents not just a crisis, but an opportunity to transform Pakistan into a self-reliant pharmaceutical powerhouse. The stark reality we face The numbers paint a sobering picture of our current vulnerability. Pakistan's complete dependency on donated and discounted vaccine supplies, supported by GAVI, UNICEF, and WHO to the tune of PKR 26 billion annually, masks a deeper structural weakness. When GAVI's support ends in 2031, the financial burden will balloon to PKR 100 billion annually as nearly four times our current federal health budget of PKR 27 billion. This dependency is not merely financial; it represents a fundamental threat to national health security. This isn't just underdevelopment—it's a systematic surrender of national health autonomy. Today, Pakistan produces virtually no antigens for the Expanded Programme on Immunization (EPI) vaccines domestically. We lack essential seed banks, have minimal university-based vaccine development programs, and operate with regulatory guidelines that are inadequate for sophisticated vaccine manufacturing. Our clinical trial expertise remains severely limited, creating bottlenecks in bringing locally developed vaccines to market. The contrast with global pharmaceutical leaders is stark. While universities worldwide have been the birthplace of revolutionary vaccines-from the Hepatitis B vaccine developed at UC San Francisco to the Oxford-AstraZeneca Covid-19 vaccine-Pakistan's academic institutions remain largely disconnected from commercial vaccine production. Learning from global success stories International experience offers valuable lessons. India transformed itself into the 'pharmacy of the world' through strategic government support for generic manufacturing and robust regulatory frameworks. Singapore built a biomedical hub through integrated research, manufacturing, and regulatory excellence that attracted billions in global pharmaceutical investment. South Korea's government-industry partnerships created world-class biopharmaceutical capabilities. These success stories share common elements: sustained government commitment, strategic investment in infrastructure, regulatory excellence, and comprehensive talent development programs. Most importantly, they demonstrate that with the right approach, developing nations can achieve pharmaceutical self-sufficiency and even become global exporters. The Triple Helix solution The path forward requires unprecedented coordination between government, academia, and industry -what experts call the 'Triple Helix' approach. Each sector must play a distinct yet interconnected role in building national vaccine capacity. Government leadership is essential in creating policy frameworks that incentivize domestic production while providing funding for university research. Strategic assignments to national research institutions like the National Institute of Health, Centre of Excellence in Molecular Biology (CEMB), National Institute for Biotechnology and Genetic Engineering (NIBGE), International Centre for Chemical and Biological sciences (ICCBS), Karachi University, Department of Biotechnology, Dow University of Health Sciences (DUHS), etc., can accelerate vaccine development and establish crucial seed banks. Most critically, the government must develop a comprehensive national health security strategy that positions vaccine self-sufficiency as a matter of national defense. The regulatory transformation cannot be understated. Pakistan's Drug Regulatory Authority must achieve WHO Level 3 qualification and create 'regulatory sandboxes — collaborative environments where university researchers, industry partners, and regulatory experts jointly develop guidelines for the 13 critical EPI vaccine antigens. Fast-track approval pathways and clear regulatory roadmaps will accelerate the journey from laboratory research to commercial production. Formation of sandboxes by bringing together leaders of the University, Regulatory and Industry. Universities must step up as innovation engines. Institutions with BSL-III laboratories should lead development of live attenuated vaccines, while biotechnology departments focus on recombinant vaccine technologies. Specialized vaccine research centers, industry-relevant curricula, and technology transfer offices will bridge the gap between academic discovery and commercial application. State-of-the-art pilot manufacturing facilities will provide proof-of-concept capabilities essential for scaling innovations. Industry brings manufacturing excellence and market expertise to the equation. Private sector partners can transform academic research into GMP-compliant commercial production, establish robust supply chains for raw materials, and navigate complex regulatory approvals. Their distribution networks and market access capabilities will ensure that domestically produced vaccines reach every corner of Pakistan. Leading companies in Pakistan already in the field of Biopharmaceutical manufacturing must be involved in the development process. A realistic implementation roadmap Success requires a phased approach spanning six years. The foundation phase (Years 1-2) must establish policy frameworks and coordination mechanisms while launching capacity-building programmes. Infrastructure development (Years 2-4) involves scaling laboratory manufacturing capabilities, establishing vaccine testing facilities, and launching pilot production programs. The scale-up phase (Years 4-6) transitions to commercial production of EPI vaccines, regulatory approvals, and distribution network establishment. Finally, the optimization phase (Year 6+) expands manufacturing capabilities, develops advanced biologics production, and positions Pakistan as a regional pharmaceutical hub. Financial innovation will be crucial. Blended financing models combining public funding, private investment, and support from institutions like the Islamic Development Bank can mobilise the substantial capital required for drug substance manufacturing facilities. The initial investment may be significant, but the long-term savings and export potential far outweigh the costs. The economic and strategic imperative The benefits extend far beyond health security. A robust domestic vaccine industry could create over 5,000 jobs and reduce import dependency by 50 percent. More importantly, it would establish Pakistan as a regional pharmaceutical hub with significant export potential to neighboring countries and the broader Islamic world. The Covid-19 pandemic demonstrated the critical importance of pharmaceutical self-reliance. Nations with domestic production capabilities could respond rapidly to their populations' needs, while others waited months for external supplies. This lesson cannot be ignored as we face an uncertain global health landscape. The time for action is now Pakistan's demographic dividend — with 65 percent of the population under 30 — represents an unprecedented opportunity to build a knowledge-based pharmaceutical sector. However, this window will not remain open indefinitely. The GAVI deadline of 2031 provides a clear timeline for action, but preparation must begin immediately. The success of this transformation depends on political will, sustained investment, and most importantly, recognition that vaccine self-sufficiency is not a luxury but a national security imperative. Countries that fail to develop domestic pharmaceutical capabilities will remain perpetually vulnerable to supply disruptions, price volatility, and foreign policy pressures. A call to national action The establishment of National and Provincial Coordination Committees bringing together leaders from academia, industry, and regulatory agencies represents the essential first step. This must be followed by a comprehensive assessment of current capabilities, development of a detailed national vaccine strategy, and launch of pilot programmes for immediate impact. Pakistan has the intellectual capital, institutional foundation and market potential to achieve vaccine independence. What we need now is the collective will to transform this potential into reality. The health and prosperity of future generations depend on the decisions we make today. The choice is clear: remain dependent on the goodwill of international donors or invest in building a self-reliant pharmaceutical sector that serves not only Pakistan's needs but positions the nation as a leader in global health innovation. The Triple Helix approach offers a proven pathway to pharmaceutical independence-we must have the courage to take it. Copyright Business Recorder, 2025
Express Tribune
3 days ago
- Express Tribune
Vietnam ends two-child limit as birth rate plummets
Listen to article Vietnam has officially ended a decades-old policy restricting families to no more than two children, state media said on Wednesday, as the country struggles with a rapidly declining birth rate and an ageing population. The regulation, first introduced in 1988, will no longer apply, with family size now left to the discretion of couples, according to the Vietnam News Agency. The change was approved by the National Assembly Standing Committee in Hanoi on Tuesday. The shift follows alarming demographic trends. In December, the country's total fertility rate dropped to a record low of 1.91 children per woman. That marks the third consecutive year the rate has fallen below the replacement level of 2.1. Vietnam's fertility rate stood at 2.11 in 2021 before slipping to 2.01 in 2022 and 1.96 in 2023, the Ministry of Health reported. Falling birth rates are particularly stark in major cities such as Hanoi and Ho Chi Minh City, where urbanisation and rising living costs have made parenting less financially feasible. 'Even though I am Asian, with social norms that say women need to get married and have kids, it's too costly to raise a child,' said 22-year-old office worker Tran Minh Huong. She said the policy change made no difference to her plans. Under the previous rules, most families were limited to one or two children, with exceptions granted in special cases. While enforcement was inconsistent, Communist Party members who violated the policy risked penalties, including demotions or dismissal. Deputy Health Minister Nguyen Thi Lien Huong recently warned that despite policy shifts and public awareness campaigns, it remains difficult to persuade families to have more children. She cited concerns about long-term socio-economic development, including labour shortages and population ageing. Vietnam is also grappling with a persistent gender imbalance. The health ministry on Tuesday proposed tripling the fine for foetal sex selection to US$3,800 to deter the practice. Although the gender ratio has improved, it remains skewed at 112 boys for every 100 girls. Hoang Thi Oanh, 45, who has three children, said she received reduced benefits for her youngest due to the old policy. 'It's good that at last the authorities removed this ban,' she said, but added that the cost of raising children remains a major barrier. Experts say that without significant support measures such as financial incentives, Vietnam may follow the same path as China. Beijing ended its one-child policy in 2016 and began allowing three-child families in 2021, yet birth rates have continued to fall amid economic pressures. The United Nations Population Fund warned that Vietnam is 'in the period of population ageing' and predicted it will become an 'aged society' within two decades.
Business Recorder
3 days ago
- Business Recorder
Communicable diseases: Need for collaboration to create awareness stressed
ISLAMABAD: The Director General (DG) Health of Federal Directorate of Immunization (FDI) has stressed the need for close collaboration between the government agencies and the civil society organisations (CSOs) to create awareness on various communicable viral diseases including poliovirus. Speaking at an event, Dr Shabana Saleem, DG Health FDI here on Tuesday said that SCOs engagement will help bridge remaining gaps in routine immunisation coverage, especially in remote and underserved areas through advocacy, demand generation, and service delivery. The meeting marked the beginning of a transformative phase in Pakistan's Expanded Programme on Immunisation (EPI), highlighting the significant role CSOs can play in reaching underserved populations. Dr Saleem welcomed representatives from CSOs, partner organisations, and the EPI community, expressing gratitude to Gavi, Mannion Daniels (MD), Oxford Policy Management (OPM), and the 17 selected CSOs from all the four provinces for their commitment and participation. 'CSOs bring community trust, local knowledge, and grassroots presence, making them essential partners in strengthening our immunisation programme,' said Dr Saleem. These CSOs will play a pivotal role in identifying 'zero-dose' children, mobilising communities, and extending EPI services where they are needed most. The CSOs will operate as a vital extension of national and provincial EPI systems. Federal and provincial governments' leadership in CSO engagement exemplifies how strategic collaboration can drive higher immunisation coverage. Through the government's strong commitment to work closely with CSOs at the provincial level, the immunisation programme will be further strengthened to reach more children, especially those that have proven hardest to reach, stated Carrie Madison Gheen, Senior Country Manager, Gavi, the Vaccine Alliance. Karen Stephenson, Team Lead for the CSO Fund Manager Mechanism at Mannion Daniels stated: 'We are delighted that thanks to the collaboration with the FDI and Provincial partners, a diverse range of civil society organizations are now able to support Pakistan's efforts to increase immunization coverage. Civil society organizations will be able to deliver meaningful results together with the communities they work in.' Under Gavi's CSO Fund Manager Mechanism, Mannion Daniels and Oxford Policy Management are responsible for delivering fund management services. To date, this has involved a rigorous independent shortlisting and due diligence process including consultation with federal and provincial EPI leadership. This resulted in the selection of 17 CSOs to support immunisation efforts across Pakistan. Following this shortlisting and selection process, the CSO Fund Manager Mechanism in Pakistan now enters the grant implementation phase. At this point, Dr Saleem emphasised the importance of coordination between CSOs, the FDI, Provincial EPIs, and development partners. 'Clear KPIs and robust monitoring frameworks will guide this initiative to ensure transparency, accountability, and measurable results,' she stated. 'I urge all CSO partners to embrace this responsibility with integrity and commitment.' Dr Saleem thanked all participants for their dedication. 'Together, let's make this partnership a model of how governments and civil society can work hand in hand to ensure every child in Pakistan receives life-saving vaccines, regardless of geography or background.' Copyright Business Recorder, 2025
